AG-024322 | CAS#837364-57-5 | MedKoo Biosciences

Back to products

Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

MedKoo product information:

AG-024322

Description of AG-24322: AG-24322 is a second generation CDK inhibitor. This was being developed by Pfizer. In 2007, it was discontinued.

Current developer: Pfizer

MedKoo Code#: 200125
Name: AG-024322
CAS#: 837364-57-5 Synonym: code name: AG-024322; AG-24322; AG-024322. 　 IUPAC/Chemical name: N-((5-(3-(4,6-difluoro-1H-benzo[d]imidazol-2-yl)-1H-indazol-4-yl)-4-methylpyridin-3-yl)methyl)ethanamine.
Chemical structure*	Theoretical analysis
*J. Med. Chem. 2009, 52, 655–663	MedKoo Code#: 200125 Name: AG-024322 CAS#837364-57-5 Chemical Formula: C23H20F2N6 Exact Mass: 418.17175 Molecular Weight: 418.44191 Elemental Analysis: C, 66.02; H, 4.82; F, 9.08; N, 20.08
Availability and price: This agent is available through custom synthesis. To inquire quotation and lead time or to ask questions, please send email to sales@medkoo.com to describe your needs. A representative will respond your email shortly. We offer big discount for orders of bulk quantities.

Information about this agent

References

1. Williams R. Discontinued drugs in 2007: oncology drugs. Expert Opin Investig Drugs. 2008 Dec;17(12):1791-816.

2. Popowycz F, Fournet G, Schneider C, Bettayeb K, Ferandin Y, Lamigeon C, Tirado OM, Mateo-Lozano S, Notario V, Colas P, Bernard P, Meijer L, Joseph B. Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue. J Med Chem. 2009 Feb 12;52(3):655-63. PubMed PMID: 19128055

Contact MedKoo:

Email: sales@medkoo.com

(Keyword; CAS#; MedKoo code#)